close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Strona główna・Stock List・Jazz Pharmaceuticals PLC
Search

Jazz Pharmaceuticals PLC

Closed

SectorHealthcare

181.97 -0.83

Strong Buy

Price update 6 mar 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

177.21

Max

182.83

Key metrics

By Trading Economics

Income

-1.2B

-904M

Sales

72M

1.2B

P/E

Sector Avg

15.775

66.845

EPS

6.64

Profit margin

-75.426

Employees

2,890

EBITDA

43M

279M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.01% upside

Dividends

By Dow Jones

Next Earnings

5 maj 2026

Market Stats

By TradingEconomics

Market Cap

1.2B

12B

Previous open

182.8

Previous close

181.97

News Sentiment

By Acuity

43%

57%

137 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 111.22 Support & Resistance

Jazz Pharmaceuticals PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 lis 2025, 12:16 UTC

Major Market Movers

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

DJ

Read

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

25.01% upside

12 Months Forecast

Average 229.55 USD  25.01%

High 275 USD

Low 195 USD

Based on 12 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Based on 12 analysts giving stock ratings to Jazz Pharmaceuticals PLC - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 111.22Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

137 / 351 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

988.33

↑ +0.72%

JNJ

Johnson and Johnson

240.32

↑ +0.33%

ABBV

AbbVie Inc

229.95

↓-0.9%

NVS

Novartis AG

159.76

↓-0.49%

AZN

AstraZeneca PLC

194.37

↓-1.51%
help-icon Live chat